Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2004, Vol. 103, No. 7, pp. 2705-2709.
Prepublished online as a Blood First Edition Paper on December 4, 2003; DOI 10.1182/blood-2003-10-3552.


This Article
Right arrow Full Text (PDF)
Right arrow Erratum (v103,p3643)
Right arrow All Versions of this Article:
2003-10-3552v1
103/7/2705    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sayeh, E.
Right arrow Articles by Semple, J. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sayeh, E.
Right arrow Articles by Semple, J. W
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted October 17, 2003
Accepted November 22, 2003

IgG anti-platelet immunity is dependent on an early innate natural killer cell-derived interferon-{gamma} response that is regulated by CD8+ T cells

Ebrahim Sayeh, Katherine Sterling, Edwin Speck, John Freedman, and John W Semple*

Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Canadian Blood Services, Toronto, ON, Canada
Department of Medicine, University of Toronto, Toronto, ON, Canada
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

* Corresponding author; email: semplej{at}smh.toronto.on.ca.

The mechanisms responsible for IgG immunity against allogeneic platelets are poorly understood. We studied the role that murine recipient CD8+ T and natural killer (NK) cells play in immunity against allogeneic platelets. BALB/c mice were depleted of the cells by cell-specific antibodies, transfused weekly with platelets from C57BL/6 mice and serum IgG antidonor antibodies were measured by flow cytometry. While allogeneic platelet transfusions into wild type recipients stimulated IgG antidonor antibodies in all mice by the fifth transfusion, CD8-depleted mice had significantly (p<0.001) enhanced antibody production. Isotype analysis revealed that CD8+ T cells suppressed Th2-associated IgG1 but enhanced Th1-associated IgG2a. Compared with wild type mice, platelet transfusions into CD8-depleted mice stimulated enhanced intracellular interferon (IFN)-{gamma} production by CD4 negative lymphocytes within 24 hours after the first transfusion. The early IFN-{gamma} response correlated with nitric oxide-dependent splenic cytotoxicity (p<0.001). In asialo GM1-depleted mice transfused with allogeneic platelets, the IFN-{gamma} production, splenic cytotoxicity and IgG anti-donor antibody response were significantly suppressed. These results demonstrate that IgG anti-platelet immunity is dependent on an early NK cell-derived IFN-{gamma} response that is negatively regulated by CD8+ T cells and suggest that targeting innate NK cell responses may significantly reduce platelet alloimmunization.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020